Salivary Gland Cell Sheets and Methods for their Production and Use

a salivary gland and cell sheet technology, applied in the field of salivary gland cell sheet, can solve the problems of limited treatment, slow progress in cured hyposalivation, and low level of structural organization, and achieve the effect of increasing saliva flow ra

Pending Publication Date: 2022-06-09
UNIV OF UTAH RES FOUND
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect that this patented technology can improve how cells respond when exposed to different conditions during tissue regenerative processes such as healing after injury. This involves adding specific substances into these damaged areas for better treatment purposes like promoting blood vessel growth around them.

Problems solved by technology

The technical problem addressed in this patents relates to improving treatment strategies against diseases associated with decreased production from salival sputum due to radiation exposures such as X rays and chemo radiations. Current approaches involve administered drugs like steroids but they may also cause side effects related issues. Therefore there needs an improvement method involving targeted delivery of specific agents specifically towards these targets without causing negative reactions during administration.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salivary Gland Cell Sheets and Methods for their Production and Use
  • Salivary Gland Cell Sheets and Methods for their Production and Use
  • Salivary Gland Cell Sheets and Methods for their Production and Use

Examples

Experimental program
Comparison scheme
Effect test

example 1

on and In Vitro Characterization of Mouse Submandibular Gland (SMG) Cell Sheets

[0064]Methods

[0065]Animals

[0066]Female C57BL / 6J mice 6-weeks-old, weighing approximately 17-20 g, were purchased from the Jackson Laboratory (Bar Harbor, Me.). All animal usage, anesthesia, and surgeries were conducted with the approval of the University of Utah Institutional Animal Care and Use Committee, in accordance with their strict guidelines.

[0067]Fresh SMG Cell Isolation

[0068]Mice were euthanized using 80-100 mg / kg Ketamine+5 mg / kg Xylazine followed by abdominal exsanguination. SMG were then removed, cut into small pieces and placed in a 35 ml GentleMACS™ C Tube containing 6.5% tumor dissociation enzyme mixture (Miltenyi Biotec Inc. Auburn, Calif.) in DMEM / F12 (Invitrogen, Carlsbad, Calif.). Subsequently, the tissue was dissociated using a GentleMACS (Miltenyi Biotec Inc) and incubated in a shaking water bath at 37° C. for 30 min. After three such steps and two intervening incubations, SMG ce

example 2

haracterization of Mouse Submandibular Gland (SMG) Cell Sheets

[0087]Methods

[0088]Animal Model

[0089]The wounded SMG model was created following a method reported previously (Nam et al., J Dent Res. 2017; 96:798-806; Nam et al., PLoS ONE. 2017; 12:e0187069). Briefly, C57BL / 6J mice were anesthetized with 3% isoflurane with an oxygen flow rate set at 2.0 L / min, SMGs were exposed and surgical wounds created using a 3 mm diameter biopsy punch. The treatment groups were as follows: (1) wounded and treated with a single layer cell sheet (experimental group SC), (2) wounded and treated with a double layer cell sheet (experimental group DC), (3) untreated wounded control or (4) unwounded (sham surgery controls). After surgery, the skin incision was sutured, and post-surgical studies were performed at day 8 or 20. For these purposes, SMG were dissected and processed for histological analysis and saliva secretion studies as described below.

[0090]Saliva Flow Rate Measurements

[0091]To collect st

example 3

on of Human Submandibular Gland (SMG) Cell Sheets

[0103]To isolate human SMG cells for preparation of cell sheets, human SMG tissue (about 100 mg) was cut into small pieces and placed in a 35 ml GentleMACS™ C Tube containing 6.5% tumor dissociation enzyme mixture (Miltenyi Biotec Inc. Auburn, Calif.) in DMEM / F12 (Invitrogen, Carlsbad, Calif.). The tissue was dissociated using a GentleMACS dissociator and incubated in a shaking water bath at 37° C. for 30 min. After three dissociation steps and two incubation steps, SMG cells were centrifuged at 150×g for 5 min at 4° C. and the medium was removed. The cells were then resuspended in 5 ml DMEM / F12 complete medium containing the following: 2.5% FBS, 2 nM triiodothyronine, 0.1 μM retinoic acid, 0.4 μg / ml hydrocortisone, 80 ng / ml EGF, 5 ng / ml sodium selenite, 5 mM glutamine, 5 μg / ml insulin and 5 μg / ml transferrin, and passed through 70 μm and 40 μm strainers (Thermo Fisher Scientific, Waltham, Mass.). Then, 1.5×106 cells were s

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The disclosure provides a salivary gland (SG) cell sheet comprising one or more layers of confluent SG cells (e.g. submandibular gland (SMG) cells). Methods of treating a wound in a salivary gland (SG), treating hyposalivation, and treating irradiation damage in an SG are also provided. The disclosure also provides a method for producing SG cell sheets comprising culturing SG cells in culture solution on a temperature-responsive polymer which has been coated onto a substrate surface of a cell culture support, wherein the temperature-responsive polymer has a lower critical solution temperature in water of 0-80° C.; adjusting the temperature of el the culture solution to below the lower critical solution temperature, whereby the substrate surface is made hydrophilic and adhesion of the cell sheet to the surface is weakened; and detaching the cell sheet from the culture support.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner UNIV OF UTAH RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products